Adecatumumab (Anti-EpCAM / TROP1 / CD326)
Adecatumumab (Anti-EpCAM / TROP1 / CD326) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status. MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2512 |
Sku # | A2512-1mg*5 |
Pricing | 1mg*5, $970.00 |